Prelude Therapeutics Inc Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Prelude Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q2 2024.
  • Prelude Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending August 7, 2024 was 55M shares, a 0.39% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 55M +216K +0.39% Aug 7, 2024 10-Q 2024-08-12
Q1 2024 54.9M +7.02M +14.6% May 1, 2024 10-Q 2024-05-07
Q4 2023 54.9M Feb 9, 2024 10-K 2024-02-15
Q3 2023 54.8M +6.97M +14.6% Oct 27, 2023 10-Q 2023-11-01
Q2 2023 54.8M +6.98M +14.6% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 47.9M +281K +0.59% Mar 9, 2023 10-K 2023-03-15
Q3 2022 47.9M +644K +1.37% Nov 8, 2022 10-Q 2022-11-14
Q2 2022 47.8M +740K +1.57% Aug 2, 2022 10-Q 2022-08-09
Q1 2022 47.6M +1.05M +2.25% Mar 11, 2022 10-K 2022-03-17
Q3 2021 47.2M +3.51M +8.04% Nov 8, 2021 10-Q 2021-11-12
Q2 2021 47.1M Aug 9, 2021 10-Q 2021-08-12
Q1 2021 46.6M Mar 12, 2021 10-K 2021-03-16
Q3 2020 43.7M Nov 10, 2020 10-Q 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.